Logo image of USAP

UNIVERSAL STAINLESS & ALLOY (USAP) Stock Fundamental Analysis

USA - NASDAQ:USAP - US9138371003 - Common Stock

44.99 USD
+0.41 (+0.92%)
Last: 1/22/2025, 8:00:02 PM
44.9925 USD
+0 (+0.01%)
After Hours: 1/22/2025, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, USAP scores 5 out of 10 in our fundamental rating. USAP was compared to 156 industry peers in the Metals & Mining industry. USAP has only an average score on both its financial health and profitability. USAP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year USAP was profitable.
USAP had a positive operating cash flow in the past year.
In multiple years USAP reported negative net income over the last 5 years.
In multiple years USAP reported negative operating cash flow during the last 5 years.
USAP Yearly Net Income VS EBIT VS OCF VS FCFUSAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

USAP has a Return On Assets of 7.17%. This is amongst the best in the industry. USAP outperforms 81.38% of its industry peers.
With a decent Return On Equity value of 10.52%, USAP is doing good in the industry, outperforming 78.62% of the companies in the same industry.
USAP has a better Return On Invested Capital (9.28%) than 82.76% of its industry peers.
Industry RankSector Rank
ROA 7.17%
ROE 10.52%
ROIC 9.28%
ROA(3y)-0.36%
ROA(5y)-1.24%
ROE(3y)-0.62%
ROE(5y)-1.7%
ROIC(3y)N/A
ROIC(5y)N/A
USAP Yearly ROA, ROE, ROICUSAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5 -10

1.3 Margins

USAP has a Profit Margin of 8.14%. This is in the better half of the industry: USAP outperforms 78.62% of its industry peers.
USAP's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 11.59%, USAP is doing good in the industry, outperforming 68.28% of the companies in the same industry.
USAP's Operating Margin has declined in the last couple of years.
USAP has a Gross Margin (21.62%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of USAP has remained more or less at the same level.
Industry RankSector Rank
OM 11.59%
PM (TTM) 8.14%
GM 21.62%
OM growth 3YN/A
OM growth 5Y-5.23%
PM growth 3YN/A
PM growth 5Y-16.31%
GM growth 3YN/A
GM growth 5Y-0.33%
USAP Yearly Profit, Operating, Gross MarginsUSAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USAP is destroying value.
The number of shares outstanding for USAP has been increased compared to 1 year ago.
Compared to 5 years ago, USAP has more shares outstanding
The debt/assets ratio for USAP has been reduced compared to a year ago.
USAP Yearly Shares OutstandingUSAP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
USAP Yearly Total Debt VS Total AssetsUSAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.44 indicates that USAP is not in any danger for bankruptcy at the moment.
The Altman-Z score of USAP (4.44) is better than 66.90% of its industry peers.
USAP has a debt to FCF ratio of 3.64. This is a good value and a sign of high solvency as USAP would need 3.64 years to pay back of all of its debts.
USAP has a Debt to FCF ratio of 3.64. This is in the better half of the industry: USAP outperforms 72.41% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that USAP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.26, USAP is in line with its industry, outperforming 41.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 3.64
Altman-Z 4.44
ROIC/WACC0.83
WACC11.17%
USAP Yearly LT Debt VS Equity VS FCFUSAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

USAP has a Current Ratio of 4.38. This indicates that USAP is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.38, USAP is in the better half of the industry, outperforming 77.93% of the companies in the same industry.
USAP has a Quick Ratio of 1.35. This is a normal value and indicates that USAP is financially healthy and should not expect problems in meeting its short term obligations.
USAP has a Quick ratio (1.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.38
Quick Ratio 1.35
USAP Yearly Current Assets VS Current LiabilitesUSAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1694.12% over the past year.
The earnings per share for USAP have been decreasing by -16.94% on average. This is quite bad
Looking at the last year, USAP shows a very strong growth in Revenue. The Revenue has grown by 24.80%.
USAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.24% yearly.
EPS 1Y (TTM)1694.12%
EPS 3YN/A
EPS 5Y-16.94%
EPS Q2Q%455%
Revenue 1Y (TTM)24.8%
Revenue growth 3Y16.75%
Revenue growth 5Y2.24%
Sales Q2Q%22.47%

3.2 Future

Based on estimates for the next years, USAP will show a very strong growth in Earnings Per Share. The EPS will grow by 156.90% on average per year.
Based on estimates for the next years, USAP will show a small growth in Revenue. The Revenue will grow by 6.33% on average per year.
EPS Next Y546%
EPS Next 2Y156.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.33%
Revenue Next 2Y6.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USAP Yearly Revenue VS EstimatesUSAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
USAP Yearly EPS VS EstimatesUSAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.60, which indicates a correct valuation of USAP.
USAP's Price/Earnings ratio is a bit cheaper when compared to the industry. USAP is cheaper than 73.10% of the companies in the same industry.
USAP is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.37, USAP is valued correctly.
USAP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. USAP is cheaper than 67.59% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of USAP to the average of the S&P500 Index (22.88), we can say USAP is valued slightly cheaper.
Industry RankSector Rank
PE 16.6
Fwd PE 13.37
USAP Price Earnings VS Forward Price EarningsUSAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USAP indicates a somewhat cheap valuation: USAP is cheaper than 66.90% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, USAP is valued a bit cheaper than 75.17% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.03
EV/EBITDA 8.35
USAP Per share dataUSAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

USAP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
USAP's earnings are expected to grow with 156.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y156.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for USAP!.
Industry RankSector Rank
Dividend Yield N/A

UNIVERSAL STAINLESS & ALLOY

NASDAQ:USAP (1/22/2025, 8:00:02 PM)

After market: 44.9925 +0 (+0.01%)

44.99

+0.41 (+0.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)01-22 2025-01-22/bmo
Earnings (Next)N/A N/A
Inst Owners66.11%
Inst Owner Change-44.61%
Ins Owners6.18%
Ins Owner Change0%
Market Cap418.86M
Analysts43.33
Price Target46.92 (4.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.19%
Min EPS beat(2)6.69%
Max EPS beat(2)69.68%
EPS beat(4)3
Avg EPS beat(4)22.71%
Min EPS beat(4)-17.28%
Max EPS beat(4)69.68%
EPS beat(8)7
Avg EPS beat(8)31.78%
EPS beat(12)8
Avg EPS beat(12)11.84%
EPS beat(16)10
Avg EPS beat(16)11.48%
Revenue beat(2)2
Avg Revenue beat(2)1.25%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.54%
Revenue beat(4)2
Avg Revenue beat(4)-0.47%
Min Revenue beat(4)-3.81%
Max Revenue beat(4)1.54%
Revenue beat(8)4
Avg Revenue beat(8)0.96%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)7
Avg Revenue beat(16)-1.25%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)43.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.26%
Valuation
Industry RankSector Rank
PE 16.6
Fwd PE 13.37
P/S 1.28
P/FCF 22.03
P/OCF 11.39
P/B 1.65
P/tB 1.65
EV/EBITDA 8.35
EPS(TTM)2.71
EY6.02%
EPS(NY)3.37
Fwd EY7.48%
FCF(TTM)2.04
FCFY4.54%
OCF(TTM)3.95
OCFY8.78%
SpS35.17
BVpS27.2
TBVpS27.2
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.17%
ROE 10.52%
ROCE 11.74%
ROIC 9.28%
ROICexc 9.28%
ROICexgc 9.28%
OM 11.59%
PM (TTM) 8.14%
GM 21.62%
FCFM 5.81%
ROA(3y)-0.36%
ROA(5y)-1.24%
ROE(3y)-0.62%
ROE(5y)-1.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-4.38%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.38%
OM growth 3YN/A
OM growth 5Y-5.23%
PM growth 3YN/A
PM growth 5Y-16.31%
GM growth 3YN/A
GM growth 5Y-0.33%
F-Score8
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 3.64
Debt/EBITDA 1.12
Cap/Depr 86.51%
Cap/Sales 5.43%
Interest Coverage 250
Cash Conversion 62.9%
Profit Quality 71.33%
Current Ratio 4.38
Quick Ratio 1.35
Altman-Z 4.44
F-Score8
WACC11.17%
ROIC/WACC0.83
Cap/Depr(3y)62.34%
Cap/Depr(5y)64.96%
Cap/Sales(3y)5.89%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1694.12%
EPS 3YN/A
EPS 5Y-16.94%
EPS Q2Q%455%
EPS Next Y546%
EPS Next 2Y156.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.8%
Revenue growth 3Y16.75%
Revenue growth 5Y2.24%
Sales Q2Q%22.47%
Revenue Next Year16.33%
Revenue Next 2Y6.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y555.2%
EBIT growth 3YN/A
EBIT growth 5Y-3.1%
EBIT Next Year348.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y154.35%
FCF growth 3Y-5.9%
FCF growth 5Y58.5%
OCF growth 1Y289.52%
OCF growth 3Y1.95%
OCF growth 5Y8.72%